IQVIA Holdings Inc. has demonstrated remarkable revenue growth driven by its integrated healthcare intelligence platform that combines proprietary data, advanced AI, and technology solutions. While operating income has remained relatively stable, pressure on margins reflects investments and competitive pricing dynamics. The company's vast data assets, including 1.2 billion unique patient records and 68 petabytes of information, underpin a formidable competitive moat difficult to replicate. IQVIA's capital allocation strategy includes significant share repurchases alongside disciplined debt management, sustaining an attractive return on equity near 21%. Regulatory complexities and ongoing litigation present risks that may affect operational resilience going forward.